Allozyne
Allozyne develops technologies that improve the efficacy, safety, dosing, and other characteristics of protein-based therapeutics.
Launch date
Employees
Market cap
-
Enterprise valuation
$6m (Public information from Sep 2014)
Seattle Washington (HQ)
Authorizing premium user...